These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 21761282

  • 1. Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
    Ekholm E, Shaat N, Holst JJ.
    Acta Diabetol; 2012 Oct; 49(5):349-54. PubMed ID: 21761282
    [Abstract] [Full Text] [Related]

  • 2. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP, Bacon S, Pannu KK, Rizvi SR, Colclough K, Ellard S, Byrne MM.
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A, Bagger JI, Ferrannini E, Holst JJ, Knop FK, Vilsbøll T, Mari A.
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
    [Abstract] [Full Text] [Related]

  • 5. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH.
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3.
    Østoft SH, Bagger JI, Hansen T, Pedersen O, Holst JJ, Knop FK, Vilsbøll T.
    Diabetes; 2014 Aug; 63(8):2838-44. PubMed ID: 24677712
    [Abstract] [Full Text] [Related]

  • 11. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.
    Urbanova J, Andel M, Potockova J, Klima J, Macek J, Ptacek P, Mat'oska V, Kumstyrova T, Heneberg P.
    Curr Pharm Des; 2015 Aug; 21(39):5736-48. PubMed ID: 26446475
    [Abstract] [Full Text] [Related]

  • 12. Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses.
    Rijkelijkhuizen JM, McQuarrie K, Girman CJ, Stein PP, Mari A, Holst JJ, Nijpels G, Dekker JM.
    Metabolism; 2010 Apr; 59(4):502-11. PubMed ID: 19846181
    [Abstract] [Full Text] [Related]

  • 13. Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY.
    Broome DT, Mehdi A, Chase C, de Freitas MF, Gregg BE, Oral EA, Herman WH.
    Diabetes Care; 2024 Sep 01; 47(9):e65-e66. PubMed ID: 39008714
    [No Abstract] [Full Text] [Related]

  • 14. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE, Shepherd MH, McDonald TJ, Shields BM, Knight BA, Ellard S, Hattersley AT.
    Diabetes Care; 2011 Feb 01; 34(2):286-91. PubMed ID: 21270186
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S.
    Hum Mutat; 2013 May 01; 34(5):669-85. PubMed ID: 23348805
    [Abstract] [Full Text] [Related]

  • 17. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF, Nilas L, Madsbad S, Holst JJ.
    Metabolism; 2009 May 01; 58(5):586-93. PubMed ID: 19375579
    [Abstract] [Full Text] [Related]

  • 18. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.
    Diabetologia; 2002 Aug 01; 45(8):1111-9. PubMed ID: 12189441
    [Abstract] [Full Text] [Related]

  • 19. Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young.
    Østoft SH, Bagger JI, Hansen T, Hartmann B, Pedersen O, Holst JJ, Knop FK, Vilsbøll T.
    Eur J Endocrinol; 2015 Aug 01; 173(2):205-15. PubMed ID: 25953829
    [Abstract] [Full Text] [Related]

  • 20. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB, Jacobsen SH, Dirksen C, Bojsen-Møller KN, Naver L, Hvolris L, Clausen TR, Wulff BS, Worm D, Lindqvist Hansen D, Madsbad S, Holst JJ.
    Am J Physiol Endocrinol Metab; 2012 Jul 01; 303(1):E122-31. PubMed ID: 22535748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.